Here, we report an original study investigating the effects of dual inhibition of PI3K and mTOR in human leiomyosarcomas on anti-tumor activity, especially the biological consequences on components of the PI3K/AKT/mTOR and RAS/MEK/ERK pathways. The gene discussed is AKT1; the disease is leiomyosarcoma.